Alaa A-M Abdel-Aziz

18PUBLICATIONS
38CO-AUTHORS
Predictive and prognostic markersCheminformatics and quantitative structure-activity relationshipsBiologically active moleculesMolecular targetsBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Apr 24, 2026
Discovery of thieno[2,3-d]pyrimidine-based dual Aurora B/VEGFR-2 inhibitors with potent anticancer activity: molecular docking, mechanistic studies, and in vivo validation in a breast cancer model.

|Apr 26, 2025
Synthesis, Antitumor Activities, and Apoptosis-Inducing Activities of Schiff's Bases Incorporating Imidazolidine-2,4-dione Scaffold: Molecular Docking Studies and Enzymatic Inhibition Activities.

Fhdah S Alanazi, Hamad M Alkahtani, Alaa A-M Abdel-Aziz

|Jan 08, 2025
Antitumor Activity and Multi-Target Mechanism of Phenolic Schiff Bases Bearing Methanesulfonamide Fragments: Cell Cycle Analysis and a Molecular Modeling Study.

Alaa A-M Abdel-Aziz, Adel S El-Azab, Simone Brogi

|Jan 07, 2025
Remarkable utilization of quinazoline-based homosulfonamide for in vitro cytotoxic effects with triple kinase inhibition activities: cell cycle analysis and molecular docking profile.

Adel S El-Azab, Alaa A-M Abdel-Aziz, Ahmed H Bakheit

|Aug 21, 2024
S-Alkylated quinazolin-4(3H)-ones as dual EGFR/VEGFR-2 kinases inhibitors: design, synthesis, anticancer evaluation and docking study.

Samar S Tawfik, Abdelrahman Hamdi, Ahmed R Ali

|Jul 15, 2024
Synthesis, enzyme inhibition assay, and molecular modeling study of novel pyrazolines linked to 4-methylsulfonylphenyl scaffold: antitumor activity and cell cycle analysis.

Alaa A-M Abdel-Aziz, Adel S El-Azab, Simone Brogi

Pageof 3

Frequent Collaborators

14 joint publications

Adel S El-Azab

6 joint publications

Hamad M Alkahtani

5 joint publications

Magda A-A El-Sayed

3 joint publications

Claudiu T Supuran